The stroke (STK) measures were developed in collaboration with the American Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition (BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers. In 2009, the STK eight-measure set was approved as a core measure set for use in the Joint Commission’s ORYX program, and may be selected by hospitals to meet their six core measure set accreditation requirement, dependent upon vendor support of this measure set. The measure maintenance process is guided by expertise and advice provided by the Stroke Measure Maintenance Technical Advisory Panel. Seven measures in the stroke set were re-endorsed by the National Quality Forum (NQF) on November 1, 2012; endorsement for the stroke education measure was removed.
STK measure specifications are aligned with the Centers for Medicare & Medicaid Services as well as harmonized with data elements contained in the AHA Get With The Guidelines SM (GWTG)-Stroke patient management tool and the Centers for Disease Control and Prevention (CDC) Paul Coverdell National Acute Stroke Registry (PCNASR). Effective January 1, 2016, STK-4 Thrombolytic Therapy is the only chart-abstracted measure in the stroke core measure set required for the CMS Hospital Inpatient Quality Reporting Program and to meet Joint Commission ORYX® Performance Measurement Requirements for hospital accreditation purposes.
The STK measures can be found in the Specification Manual for National Hospital Inpatient Quality Measures. Specifications for the STK electronic clinical quality measures (eCQMs) are available at: https://www.cms.gov/Regulations-and Guidance/Legislation/EHRIncentivePrograms/Downloads/eCQM_2014_EH_June2015.zip.
Submit your questions about STK measure specifications to the Performance Measurement Network Q&A Forum.